Birth cohort differences in hypertension control in a brazilian population of older elderly: The bambuí cohort study of aging (1997 and 2008);Diferenças de coorte por nascimento no controle da hipertensão entre idosos mais velhos: Estudo de coorte de idosos de bambuí (1997 e 2008)

Cadernos de Saude Publica

Volumn 27, Issue SUPPL. 3, 2011, Pages

  Firmo, Josélia O A ^a   Peixoto, Sérgio Viana ^a   de Loyola Filho, Antônio Ignácio ^a   Uchôa, Elizabeth ^a   Lima Costa, Maria Fernanda ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Aged; Cohort studies; Hypertension

Indexed keywords

AGED; ARTICLE; BRAZIL; COHORT ANALYSIS; FEMALE; HUMAN; HYPERTENSION; MALE; PREVALENCE;

AGED; AGED, 80 AND OVER; BRAZIL; COHORT STUDIES; FEMALE; HUMANS; HYPERTENSION; MALE; PREVALENCE;

EID: 80053263671     PISSN: 0102311X     EISSN: 16784464     Source Type: Journal    
DOI: 10.1590/S0102-311X2011001500013     Document Type: Article

References (24)

1. Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJ; Comparative Risk Assessment Collaborating Group. Selected major risk factors and global and regional burden of disease. Lancet 2002; 360:1347-60
2. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365: 217-23.
3. World Health Organization. The World Health Report 2002: reducing risks, promoting healthy life. Geneva: World Health Organization; 2002.
4. Healthy People. Heart disease and stroke. http://www.healthypeople.gov/Document/HTML/volume1/12Heart.htm (accessed on 30/Apr/2010).
5. Kannel WB. Hypertension: reflections on risks and prognostication. Med Clin North Am 2009; 93: 541-58.
6. Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, et al. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (comprising representatives of nine societies and guest experts). Eur Heart J 2007; 28:2375-414.
7. Departamento de Atenção Básica, Secretaria de Atenção à Saúde, Ministério da Saúde. Hipertensão arterial sistêmica para o Sistema Único de Saúde. Brasília: Ministério da Saúde; 2006. (Cadernos de Atenção Básica, 16).
8. Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA 2010; 303:2043-50.
9. Keenan NL, Rosendorf KA; Centers for Disease Control and Prevention. Prevalence of hypertension and controlled hypertension - United States, 2005-2008. MMWR Surveill Summ 2011; 60 Suppl:94-7.
10. Leenen FHH, Dumais J, McInnis NH, Turton P, Stratychuk L, Nemeth K, et al. Results of the Ontario survey on the prevalence and control of hypertension. CMAJ 2008; 178:1441-9.
11. Damasceno A, Azevedo A, Silva-Matos C, Prista A, Diogo D, Lunet N. Hypertension prevalence, awareness, treatment, and control in Mozambique: urban/rural gap during epidemiological transition. Hypertension 2009, 54:77-83.
12. Firmo JOA, Barreto SM, Lima-Costa MF. The Bambui Health and Aging Study (BHAS): factors associated with the treatment of hypertension in older adults in the community. Cad Saúde Pública 2003; 19:817-27.
13. Lima-Costa MF, Firmo JOA, Uchôa E. Cohort profile: the Bambui (Brazil) Cohort Study of Aging. Int J Epidemiol 2010; [Epub ahead of print].
14. Lima-Costa MF, Firmo JOA, Uchôa E. The Bambuí Cohort Study of Aging: methodology and health profile of participants at baseline. Cad Saúde Pública 2011; 27 Suppl 3:S327-35.
15. U.S. Department of Health and Human Services/ National Institutes of Health/National Heart, Lung, and Blood Institute/National High Blood Pressure Education Program. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Washington DC: U.S. Department of Health and Human Services/National Institutes of Health/National Heart, Lung, and Blood Institute/National High Blood Pressure Education Program; 2004. (NIH Publication, 04-5230).
16. WHO Collaborating Centre for Drug Statistics Methodology/ Norwegian Institute of Public Health. Guidelines for ATC classification and DDD assignment. 13th Ed. Oslo: WHO Collaborating Centre for Drug Statistics Methodology/Norwegian Institute of Public Health; 2009.
17. Bineau S, Dufouil C, Helmer C, Ritchie K, Empana J-P, Ducimetière P, et al. Framingham stroke risk function in a large population-based cohort of elderly people: the 3C study. Stroke 2009; 40:1564-70.
18. Vasan RS, Kannel WB. Strategies for cardiovascular risk assessment and prevention over the life course. Circulation 2009; 120:360-3.
19. D'Agostino RB, Wolf PA, Belanger AJ, Kannel WB. Probability of stroke: a risk profile from the Framingham. Stroke 1991; 22:312-8.
20. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr. JL, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289: 2560-72.
21. Pierin AMG. Orientação sistematizada do paciente hipertenso submetido a tratamento ambulatorial. Rev Esc Enferm USP 1986; 20:193-205.
22. Klein CH, Araújo JWG. Fumo, bebida alcóolica, migração, instrução, ocupação, agregação familiar e pressão arterial em Volta Redonda, Rio de Janeiro. Cad Saúde Pública 1985; 1:160-76.
23. Firmo JOA, Lima-Costa MF, Uchôa E. Projeto Bambuí: maneiras de pensar e agir de idosos hipertensos. Cad Saúde Pública 2004; 20:1029-40.
24. Chobanian AV. Shattuck lecture: the hypertension paradox - more uncontrolled disease despite improved therapy. N Engl J Med 2009; 361:878-87.